The U.S. Postal Service faces a looming financial crisis that poses a challenge to its survival.

China is banking on its dominance of global supply chains to help it ride out the pain from Donald Trump’s trade war.

As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.

Certain shifts in business strategy seem so shockingly obvious in retrospect that you have to wonder why they weren’t common practice all along.

The U.S.-China trade war is miring global supply chains in increasing uncertainty — with over half of U.S. companies with global supply chains reporting adverse impact.